Consumer Marketing Briefs

Share this article:
Consumer Reports took a jab at Boniva ads starring Sally Field in an episode of its Adwatch online video series, which has previously tackled spots for Cialis, Rozerem, Requip and Chantix. Associate editor Jamie Hirsch concluded: “Bottom line—Sally's a great spokesperson and we do like her. But we think you should ask your doctor whether you really need such an expensive bisphosphonate.”

DDMAC is adding a third review group for consumer promotions to keep up with surging submissions. The third group will be led by Sangeeta Vaswani, previously acting leader for Professional Review Group III, according to Marci Keister, who heads DTC Review Group II.  

Reps. James Moran (D-VA) and Robert Brady (D-PA) introduced a bill, dubbed the “Families for ED Advertising Decency Act,” that would ban ED ads on radio or TV between the hours of 6:00 am and 10:00 pm —an edict that would comport, more or less, with existing guidelines of PhRMA and individual manufacturers. Moran contends that weekend daytime sporting events are nonetheless “saturated” with ED ads, and wants to empower the FCC to fine broadcasters that air them between those hours.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets